152 related articles for article (PubMed ID: 23234550)
1. Antimalarial aminothiazoles and aminopyridines from phenotypic whole-cell screening of a SoftFocus(®) library.
Paquet T; Gordon R; Waterson D; Witty MJ; Chibale K
Future Med Chem; 2012 Dec; 4(18):2265-77. PubMed ID: 23234550
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activity.
Younis Y; Douelle F; González Cabrera D; Le Manach C; Nchinda AT; Paquet T; Street LJ; White KL; Zabiulla KM; Joseph JT; Bashyam S; Waterson D; Witty MJ; Wittlin S; Charman SA; Chibale K
J Med Chem; 2013 Nov; 56(21):8860-71. PubMed ID: 24099149
[TBL] [Abstract][Full Text] [Related]
3. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.
Le Manach C; Gonzàlez Cabrera D; Douelle F; Nchinda AT; Younis Y; Taylor D; Wiesner L; White KL; Ryan E; March C; Duffy S; Avery VM; Waterson D; Witty MJ; Wittlin S; Charman SA; Street LJ; Chibale K
J Med Chem; 2014 Mar; 57(6):2789-98. PubMed ID: 24568587
[TBL] [Abstract][Full Text] [Related]
4. Cell-based medicinal chemistry optimization of high throughput screening hits for orally active antimalarials. Part 2: hits from SoftFocus kinase and other libraries.
Younis Y; Street LJ; Waterson D; Witty MJ; Chibale K
J Med Chem; 2013 Oct; 56(20):7750-4. PubMed ID: 23927599
[TBL] [Abstract][Full Text] [Related]
5. Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
Hameed P S; Chinnapattu M; Shanbag G; Manjrekar P; Koushik K; Raichurkar A; Patil V; Jatheendranath S; Rudrapatna SS; Barde SP; Rautela N; Awasthy D; Morayya S; Narayan C; Kavanagh S; Saralaya R; Bharath S; Viswanath P; Mukherjee K; Bandodkar B; Srivastava A; Panduga V; Reddy J; Prabhakar KR; Sinha A; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Magistrado PA; Lukens AK; Wirth DF; Waterson D; Balasubramanian V; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK; Ramachandran S
J Med Chem; 2014 Jul; 57(13):5702-13. PubMed ID: 24914738
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial and antiplasmodial activities of norneolignans. Syntheses and SAR.
Skytte DM; Nielsen SF; Chen M; Zhai L; Olsen CE; Christensen SB
J Med Chem; 2006 Jan; 49(1):436-40. PubMed ID: 16392829
[TBL] [Abstract][Full Text] [Related]
7. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a softfocus kinase library: part 2.
Le Manach C; Paquet T; Gonzàlez Cabrera D; Younis Y; Taylor D; Wiesner L; Lawrence N; Schwager S; Waterson D; Witty MJ; Wittlin S; Street LJ; Chibale K
J Med Chem; 2014 Nov; 57(21):8839-48. PubMed ID: 25313449
[TBL] [Abstract][Full Text] [Related]
8. Bayesian models trained with HTS data for predicting β-haematin inhibition and in vitro antimalarial activity.
Wicht KJ; Combrinck JM; Smith PJ; Egan TJ
Bioorg Med Chem; 2015 Aug; 23(16):5210-7. PubMed ID: 25573118
[TBL] [Abstract][Full Text] [Related]
9. N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
Ramachandran S; Hameed P S; Srivastava A; Shanbhag G; Morayya S; Rautela N; Awasthy D; Kavanagh S; Bharath S; Reddy J; Panduga V; Prabhakar KR; Saralaya R; Nanduri R; Raichurkar A; Menasinakai S; Achar V; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Waterson D; Lee MC; Coburn-Flynn O; Fidock DA; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK
J Med Chem; 2014 Aug; 57(15):6642-52. PubMed ID: 25007124
[TBL] [Abstract][Full Text] [Related]
10. Novel orally active antimalarial thiazoles.
González Cabrera D; Douelle F; Feng TS; Nchinda AT; Younis Y; White KL; Wu Q; Ryan E; Burrows JN; Waterson D; Witty MJ; Wittlin S; Charman SA; Chibale K
J Med Chem; 2011 Nov; 54(21):7713-9. PubMed ID: 21966980
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of novel benzoxaboroles as a new class of antimalarial agents.
Zhang YK; Plattner JJ; Freund YR; Easom EE; Zhou Y; Gut J; Rosenthal PJ; Waterson D; Gamo FJ; Angulo-Barturen I; Ge M; Li Z; Li L; Jian Y; Cui H; Wang H; Yang J
Bioorg Med Chem Lett; 2011 Jan; 21(2):644-51. PubMed ID: 21195617
[TBL] [Abstract][Full Text] [Related]
12. 3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential.
Younis Y; Douelle F; Feng TS; González Cabrera D; Le Manach C; Nchinda AT; Duffy S; White KL; Shackleford DM; Morizzi J; Mannila J; Katneni K; Bhamidipati R; Zabiulla KM; Joseph JT; Bashyam S; Waterson D; Witty MJ; Hardick D; Wittlin S; Avery V; Charman SA; Chibale K
J Med Chem; 2012 Apr; 55(7):3479-87. PubMed ID: 22390538
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies of antiplasmodial aminomethylthiazoles.
Cheuka PM; Cabrera DG; Paquet T; Chibale K
Bioorg Med Chem Lett; 2014 Nov; 24(22):5207-11. PubMed ID: 25316314
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines.
González Cabrera D; Douelle F; Younis Y; Feng TS; Le Manach C; Nchinda AT; Street LJ; Scheurer C; Kamber J; White KL; Montagnat OD; Ryan E; Katneni K; Zabiulla KM; Joseph JT; Bashyam S; Waterson D; Witty MJ; Charman SA; Wittlin S; Chibale K
J Med Chem; 2012 Dec; 55(24):11022-30. PubMed ID: 23189922
[TBL] [Abstract][Full Text] [Related]
15. Whole-cell in vitro screening for gametocytocidal compounds.
Lucantoni L; Avery V
Future Med Chem; 2012 Dec; 4(18):2337-60. PubMed ID: 23234555
[TBL] [Abstract][Full Text] [Related]
16. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
17. 2,4-diarylthiazole antiprion compounds as a novel structural class of antimalarial leads.
Thompson MJ; Louth JC; Little SM; Chen B; Coldham I
Bioorg Med Chem Lett; 2011 Jun; 21(12):3644-7. PubMed ID: 21570837
[TBL] [Abstract][Full Text] [Related]
18. The structure-activity relationship of the antimalarial ozonide arterolane (OZ277).
Dong Y; Wittlin S; Sriraghavan K; Chollet J; Charman SA; Charman WN; Scheurer C; Urwyler H; Santo Tomas J; Snyder C; Creek DJ; Morizzi J; Koltun M; Matile H; Wang X; Padmanilayam M; Tang Y; Dorn A; Brun R; Vennerstrom JL
J Med Chem; 2010 Jan; 53(1):481-91. PubMed ID: 19924861
[TBL] [Abstract][Full Text] [Related]
19. Cell-based medicinal chemistry optimization of high-throughput screening (HTS) hits for orally active antimalarials. Part 1: challenges in potency and absorption, distribution, metabolism, excretion/pharmacokinetics (ADME/PK).
Chatterjee AK
J Med Chem; 2013 Oct; 56(20):7741-9. PubMed ID: 23927720
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimalarial activity of new atovaquone derivatives.
El Hage S; Ane M; Stigliani JL; Marjorie M; Vial H; Baziard-Mouysset G; Payard M
Eur J Med Chem; 2009 Nov; 44(11):4778-82. PubMed ID: 19747753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
